Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
to incorporate genetic test results to optimize antiplatelet drug selection after percutaneous coronary intervention and personalize warfarin dosing. Pharmacist involvement occurs on many levels, including ...
death. Skaarup et al.50 have studied 465 ACS patients treated by percutaneous coronary intervention , with a median follow-up time of 4.6 years. Endomyocardial GLS (12% vs. 17%), GLS (11% vs. 14 ...
height and weight based on growth curves could be performed . However, imputation strategy should avoid introducing biased values and thus systematic errors to the whole group. Missing data on protocols ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!